APA (7th ed.) Citation

N, G., F, I., Y, S., S, H., & T, C. An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. Dove Medical Press.

Chicago Style (17th ed.) Citation

N, Goi, Iwata F, Sugihara Y, Higa S, and Chikama T. An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. Dove Medical Press.

MLA (9th ed.) Citation

N, Goi, et al. An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. Dove Medical Press.